Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 7, 2025

Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelines Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for …

Holding(s) in Company
Reykjavík, April 07, 2025 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the …

Telix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology …

Wesdome Gold Mines to Acquire Angus Gold; Quadruples the Eagle River Land Package
All amounts are expressed in Canadian dollars unless otherwise indicated TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) and Angus Gold Inc. (TSX-V: GUS, OTC: ANGVF) (“Angus”) are …

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
HUNTSVILLE, AL, April 07, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants across cardiac biomarkers and functional measures All …

Lumissil’s Green PHY Solution Selected to Support Arrow Electronics in the new EVSE Reference Design Project
MILPITAS, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Lumissil Microsystems, an analog/mixed-signal solution provider, has been selected by Arrow Electronics to support their new Electric Vehicle Supply Equipment (EVSE) reference design, aimed at …

Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director
Accomplished biotech investor with a track record of successful company-building and exits to lead Angelini Ventures’ international BioTech investment strategy Rome, Italy, 7 April 2025 – Angelini Ventures, the corporate venture firm of Angelini …

Turntide Technologies Launches Turntide Turnkey Solutions at bauma
Alpharetta, GA, April 07, 2025 (GLOBE NEWSWIRE) -- Turntide Technologies, a leader in electrification solutions, proudly announces the launch of Turntide Turnkey Solutions, a comprehensive system of electrification partners designed to simplify and …

Perseus Mining March Quarter Report Webinar
Perth, April 07, 2025 (GLOBE NEWSWIRE) -- QUARTERLY REPORT INVESTOR WEBINAR / CALL Perth, Western Australia/April 7, 2025/Perseus Mining Limited (ASX/TSX: PRU) is hosting an investor webinar and conference call to discuss its March 2025 Quarterly Results, …